Clinical Trials in Denver

Showing 7361-7380 of 13,773 trials

Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

NCT01968083

Human respiratory syncytial virus (RSV) is a common cause of respiratory illness in infants and children. This study will evaluate the safety and immune response to an RSV vaccine in healthy RSV-naïve children.

Respiratory Syncytial Virus Infections

National Institute of Allergy and Infectious Diseases (NIAID)51 participantsStarted Oct 2013

La Jolla, California, United States • Long Beach, California, United States • Denver, Colorado, United States +2 more locations

COMPLETEDPhase 15.4 miles

Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Volunteers During a Blood Draw

NCT01834612

To determine if a manual blood loss can be detected using the non-invasive blood monitor.

Blood Loss

Zynex Monitoring Solutions20 participantsStarted Jan 2013

Lakewood, Colorado, United States

TERMINATEDPhase 36.3 miles

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01

NCT03285308

This study will evaluate the safety and efficacy of relamorelin compared to placebo in participants with diabetic gastroparesis. Participants will report daily severity scores of their diabetic gastroparesis symptoms.

GastroparesisDiabetes Mellitus

Allergan336 participantsStarted Sep 2017

Birmingham, Alabama, United States • Dothan, Alabama, United States • Huntsville, Alabama, United States +213 more locations

Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Volunteers During a Blood Draw

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01

Find Trials by Condition in Denver

Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy

Multi-Drug Resistant Organism (MDRO): Study of Highly Resistant Escherichia Coli

A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread

A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment

Natural History Study of MNGIE

Follow-up Study of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants

A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease

Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects

Phase 1 Study of BXQ-350 in Adult Patients With Advanced Solid Tumors

Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease

A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Naturalistic Setting

Scoring System for Inhalation Injury

A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia

Topical Fibrinogen-Depleted Human Platelet Lysate in Patients With Dry Eye Secondary to Graft vs. Host Disease

Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD

Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia

An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia